interleukin-21 expanded natural killer cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for interleukin-21 expanded natural killer cells, covering 2019-10-15 to 2019-10-15. Get the full timeline:
Most recent: Clinical Trial Update: Interleukin-21 (IL-21)- Expanded Natural Killer Cells for Induction of Acute Myeloid Leukemia [Phase 1, Phase 2]